Oncotelic Therapeutics (OTLC) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free OTLC Stock Alerts $0.04 +0.00 (+2.94%) (As of 04:29 PM ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Oncotelic Therapeutics Short Interest DataCurrent Short Volume11,400 sharesPrevious Short Volume400 sharesChange Vs. Previous Month+2,750.00%Dollar Volume Sold Short$468.54Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares398,670,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume22,308 sharesAverage Trading Volume70,737 sharesToday's Volume Vs. Average32% Short Selling Oncotelic Therapeutics ? Sign up to receive the latest short interest report for Oncotelic Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOTLC Short Interest Over TimeOTLC Days to Cover Over TimeOTLC Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Oncotelic Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,400 shares $468.54 +2,750.0%N/A0.1 $0.04 3/31/2024400 shares $14.39 -89.7%N/A0 $0.04 3/15/20243,900 shares $144.69 -75.2%N/A0.1 $0.04 2/29/202415,700 shares $554.21 -90.9%N/A0.1 $0.04 2/15/2024172,400 shares $6,637.40 +34.8%N/A0.9 $0.04 1/15/2024111,900 shares $4,420.05 +27,875.0%N/A1.2 $0.04 Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023400 shares $15.30 No ChangeN/A0 $0.04 12/15/2023400 shares $15.76 No ChangeN/A0 $0.04 11/30/2023400 shares $16.28 -97.6%N/A0 $0.04 11/15/202316,700 shares $542.75 -58.2%N/A0 $0.03 10/31/202339,900 shares $1,312.71 +66.3%N/A0.1 $0.03 10/15/202324,000 shares $816.00 +1,400.0%N/A0.1 $0.03 9/30/20231,600 shares $49.60 -95.4%N/A0 $0.03 9/15/202334,500 shares $1,086.75 -52.7%N/A0.1 $0.03 8/31/202372,900 shares $1,909.98 +138.2%N/A0.2 $0.03 8/15/202330,600 shares $703.80 -4.7%N/A0.3 $0.02 7/31/202332,100 shares $767.19 -50.3%N/A0.1 $0.02 7/15/202364,600 shares $1,627.92 +12.0%N/A0.1 $0.03 6/30/202357,700 shares $1,442.50 +1,054.0%N/A0 $0.03 6/15/20235,000 shares $150.00 -79.8%N/A0 $0.03 5/31/202324,700 shares $768.17 +6,075.0%N/A0.1 $0.03 5/15/2023400 shares $14.76 -55.6%N/A0 $0.04 4/30/2023900 shares $37.80 +125.0%N/A0 $0.04 4/15/2023400 shares $20.40 -99.1%N/A0 $0.05 3/31/202342,900 shares $2,037.75 +164.8%N/A0.3 $0.05 3/15/202316,200 shares $920.16 No ChangeN/A0.1 $0.06 2/28/202316,200 shares $891.00 -57.7%N/A0.1 $0.06 2/15/202338,300 shares $2,106.50 +137.9%N/A0.1 $0.06 1/31/202316,100 shares $821.10 -68.2%N/A0.1 $0.05 1/15/202350,700 shares $2,940.60 +53.6%N/A0.2 $0.06 12/30/202233,000 shares $1,485.00 +11.9%N/A0.1 $0.05 12/15/202229,500 shares $1,416.00 +2,358.3%N/A0.1 $0.05 11/30/20221,200 shares $70.32 -86.8%N/A0 $0.06 11/15/20229,100 shares $682.50 -65.5%N/A0.1 $0.08 10/31/202226,400 shares $1,188.00 -58.8%N/A0 $0.05 10/15/202264,000 shares $3,744.00 -49.7%N/A0.2 $0.06 9/30/2022127,200 shares $8,522.40 +4,286.2%N/A0.3 $0.07 9/15/20222,900 shares $205.90 -62.8%N/A0 $0.07 8/31/20227,800 shares $630.24 -77.5%N/A0 $0.08 8/15/202234,600 shares $2,899.48 -51.1%N/A0.1 $0.08Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. OTLC Short Interest - Frequently Asked Questions What is Oncotelic Therapeutics' current short interest? Short interest is the volume of Oncotelic Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,400 shares of OTLC short. Learn More on Oncotelic Therapeutics' current short interest. Is Oncotelic Therapeutics' short interest increasing or decreasing? Oncotelic Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 11,400 shares, an increase of 2,750.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Oncotelic Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Oncotelic Therapeutics: Avalo Therapeutics, Inc. (14.89%), Aytu BioPharma, Inc. (7.51%), NeuroBo Pharmaceuticals, Inc. (2.63%), Pieris Pharmaceuticals, Inc. (0.03%), Orgenesis Inc. (1.17%), Minerva Neurosciences, Inc. (0.56%), Talphera, Inc. (0.65%), Earth Science Tech, Inc. (0.00%), Cocrystal Pharma, Inc. (0.02%), Purple Biotech Ltd. (0.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Oncotelic Therapeutics stock? Short selling OTLC is an investing strategy that aims to generate trading profit from Oncotelic Therapeutics as its price is falling. OTLC shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncotelic Therapeutics? A short squeeze for Oncotelic Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OTLC, which in turn drives the price of the stock up even further. How often is Oncotelic Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OTLC, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Avalo Therapeutics Short Interest Aytu BioPharma Short Interest NeuroBo Pharmaceuticals Short Interest Pieris Pharmaceuticals Short Interest Orgenesis Short Interest Minerva Neurosciences Short Interest Talphera Short Interest Earth Science Tech Short Interest Cocrystal Pharma Short Interest Purple Biotech Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:OTLC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press